Compromised chronic efficacy of a Glucokinase Activator AZD1656 in mouse models for common human GCKR variants
Brian E. Ford, Shruti S. Chachra, Ahmed Alshawi, Fiona Oakley, Rebecca J. Fairclough, David M. Smith, DINA G. TINIAKOS, Loranne Agius
This study shows that GKRP deficiency in mouse models reduces the long-term efficacy of the GKA AZD1656 and increases liver lipid accumulation.
Biochemical Pharmacology · Aug 22, 2024Peer-reviewedPharmacology & Toxicology